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The Agility multileaf collimator (Elekta AB, Stockholm, Sweden) has 160 leaves 
of projected width 0.5 cm at the isocenter, with maximum leaf speed 3.5 cms-1. 
These characteristics promise to facilitate fast and accurate delivery of radiotherapy, 
particularly volumetric-modulated arc therapy (VMAT). The aim of this study 
is therefore to create a beam model for the Pinnacle3 treatment planning system 
(Philips Radiation Oncology Systems, Fitchburg, WI), and to use this beam model 
to explore the performance of the Agility MLC in delivery of VMAT. A 6 MV 
beam model was created and verified by measuring doses under irregularly shaped 
fields. VMAT treatment plans for five typical head-and-neck patients were created 
using the beam model and delivered using both binned and continuously variable 
dose rate (CVDR). Results were compared with those for an MLCi unit without 
CVDR. The beam model has similar parameters to those of an MLCi model, with 
interleaf leakage of only 0.2%. The verification of irregular fields shows a mean 
agreement between measured and planned dose of 1.3% (planned dose higher). 
The Agility VMAT head-and-neck plans show equivalent plan quality and deliv-
ery accuracy to those for an MLCi unit, with 95% of verification measurements 
within 3% and 3 mm of planned dose. Mean delivery time is 133 s with the Agility 
head and CVDR, 171 s without CVDR, and 282 s with an MLCi unit. Pinnacle3 
has therefore been shown to model the Agility MLC accurately, and to provide 
accurate VMAT treatment plans which can be delivered significantly faster with 
Agility than with an MLCi.
PACS number: 87.55kd, 87.55km, 87.56bd, 87.56jk
Key words: multileaf collimator, dose calculation, volumetric-modulated arc 
therapy, treatment planning system
 
I. InTroducTIon
The Agility multileaf collimator (Elekta AB, Stockholm, Sweden) has 160 leaves of projected 
width 0.5 cm at the isocenter.(1) Maximum leaf speed is 3.5 cms-1 and integrated dynamic leaf 
guides allow each whole leaf bank to further move by up to an additional 3.0 cms-1. There are 
no backup collimators. Orthogonal to the direction of leaf motion, there are sculpted collimators 
which can move at up to 9.0 cms-1. These characteristics promise to facilitate fast and accurate 
delivery of radiotherapy, particularly volumetric-modulated arc therapy (VMAT).(2)
The basic radiation characteristics of the MLC have been evaluated previously.(1) However, 
the presence of collimators in one direction in the beam’s eye view and the absence in the other 
direction, the presence of the dynamic leaf guides, and the fast motion of the MLC leaves all 
create challenges for the treatment planning system in modeling the MLC. The first goal of this 
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study is therefore to create a beam model for a commercial treatment planning system, Pinnacle3 
(Philips Radiation Oncology Systems, Fitchburg, WI), and to verify the accuracy of this beam 
model. The second goal is to use this beam model to evaluate the performance of the Agility 
MLC for delivery of VMAT. Head-and-neck cases are used for this performance evaluation, 
as these represent the most challenging cases in current clinical practice.(3,4)
 
II. MATErIALS And METHodS
A.   Agility and MLci radiation heads
The Agility radiation head is considered in this study in comparison to the MLCi head (Elekta 
AB, Stockholm, Sweden), so the features of each are briefly reviewed. The 160 MLC leaves 
of the Agility head are supported by dynamic leaf guides which are not intended to be attenu-
ating to radiation and which allow the leaves to move up to 15 cm over the central axis of the 
beam, with a speed of up to 6.5 cms-1 (Table 1). Interdigitation is supported and there are no 
backup collimators moving in the direction of leaf motion. Moving in the orthogonal direc-
tion to the MLC leaves are specially shaped collimators which can travel over the central axis 
by 12 cm.
In contrast, the standard MLCi head has 80 leaves of 1 cm width at the isocenter, which can 
overtravel the central axis by 12.5 cm. There are backup collimators which follow the rearmost 
MLC leaves to minimize interleaf leakage, but these do not contribute to the leaf speed, like 
the dynamic leaf guides on the Agility head. The orthogonal field-defining collimators are 
rectangular and they cannot travel over the central axis of the beam. Figure 1 illustrates these 
concepts. (Note that there is also an MLCi2 available which allows interdigitation; this is not 
considered in the present study.)
Table 1. Comparison of Agility and MLCi heads. Field sizes are defined at isocenter. In the ranges of travel, a negative 
value indicates the direction of insertion and a positive value indicates the direction of withdrawal.
 Characteristic Agility Head MLCi Head
Maximum field size (cm) 40 × 40 40 × 40
Leaf pitch (cm) 0.5 1.0
Xa collimator range with respect to central axis (cm) Not applicable -12.5 to 20
Leaf guide range with respect to central axis (cm) 5 to 20 Not applicable
MLC leaf range with respect to guide (cm) -20 to 0 Not applicable
MLC range with respect to central axis (cm) -15 to 20 -12.5 to 20
Ya collimator range with respect to central axis (cm) -12 to 20 0 to 20
Focus – MLC distance (cm) 31.8 29.8
MLC thickness (cm) 9.0 7.5
Maximum MLC leaf speed (cms-1) 3.5 2.0
Maximum Xa collimator / leaf guide speed (cms-1) 3.0 2.0
Maximum Ya collimator speed (cms-1) 9.0 1.5
aIEC61217 convention.
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Fig. 1. Comparative beam’s eye views of (a) Agility and (b) MLCi multileaf collimators, showing the principal differences 
in design. This is a schematic representation only and is not to scale.
(a)
(b)
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B.   Beam modeling
Depth doses and cross-beam profiles were measured with a TW60008 p-type Silicon diode 
detector (PTW, Freiburg, Germany) under a 6 MV Agility beam for square field sizes ranging 
from 3 × 3 cm to 40 × 40 cm in a plotting tank (PTW, Freiburg, Germany). Output factors were 
measured using a Type 2571 0.6 cm3 ionization chamber (Saint Gobain Crystals and Detectors, 
Reading, UK) in Solid Water (Radiation Measurements, Inc., Middleton, WI) at a depth of 
10 cm. The focus-to-surface distance (FSD) was 90 cm for both the plotting tank measurements 
and the output factor measurements. A beam model was then created in Pinnacle3 in accord 
with previously established procedures.(5) Specifically, the automodeling function in Pinnacle3 
was used initially and then final adjustments were made manually, particularly for MLC and 
collimator transmission.
The combination of the dynamic leaf guides and the MLC leaves working together meant 
that the maximum leaf speed was 6.5 cms-1, if all leaves in a bank were moving in the same 
direction, reducing to 3.5 cms-1 for the case of some leaves travelling a given distance in one 
direction and other leaves travelling the same distance in the opposite direction. This behavior 
was not modeled explicitly in the treatment planning system, so the speed of the MLC leaves 
was constrained conservatively in Pinnacle3 as 3 cms-1. Furthermore, the minimum gap between 
opposing leaves was in principle 0.5 cm at the isocentric plane, so as to maintain a separation 
of 0.1 cm at the MLC itself, allowing for the rounded ends of the MLC (physical radius 17 cm). 
However, in this study, the minimum leaf separation (“dynamic leaf gap”) was set to 2 cm so as 
to ensure that the apertures were 2 cm or larger in width, thereby allowing the dose to be calcu-
lated with greater certainty. This was in accord with current clinical practice at this center.
Treatment fields and plans were transmitted directly to the accelerator control system by 
DICOM transfer. Pinnacle3 defined two pairs of collimators, but one pair was redundant for the 
Agility head due to the absence of backup collimators. The Agility control system required this 
pair of collimators to be set to ± 20 cm, so for the purposes of DICOM transfer, a simple script 
was executed after creation of treatment plans to set the collimator positions for the redundant 
collimators to ± 20 cm. (This step is not necessary when using MOSAIQ (Elekta, Sunnyvale, 
CA) for treatment delivery.)
Nine specific fields were then created to test the beam model. These were a 5 cm × 5 cm 
field on the central axis, a 10 cm × 10 cm field on the central axis, a 30 cm × 30 cm field on the 
central axis, a 4 cm × 20 cm field on the central axis, a 20 cm × 4 cm field on the central axis, a 
20 cm × 20 cm L-shape field, a 20 cm × 20 cm S-shape field, a 5 × 5 cm field positioned 7.5 cm 
from the center of the field along one axis, and a 5 × 5 cm field positioned 7.5 cm from the center 
of the field along the other axis. Doses were calculated in a water phantom in Pinnacle3. Depth 
doses and cross-beam profiles were measured in a plotting tank for the L-shape and S-shape 
fields. For the L-shape field, both central axis profiles and off-axis profiles along the lines of the 
“L” shape were obtained. The same equipment was used as for measurement of the beam data 
(see above). A Type 2577 0.2 cm3 ionization chamber (Saint Gobain Crystals and Detectors) 
was then used to measure doses in various locations under all of these fields in Solid Water at 
10 cm depth and 90 cm FSD to verify the accuracy of the model.
The performance of the beam model for dynamic fields was also briefly demonstrated. A 
2 cm × 20 cm field was swept dynamically from 10 cm to one side of the isocenter to 10 cm to 
the other side of the isocenter and the dose at the isocenter was measured using a Type 2571 
0.6 cm3 ionization chamber. The gantry was at 0° for this test, the FSD was 90 cm, and the 
depth of the ionization chamber was 10 cm. The axis of the ionization chamber was oriented 
perpendicular to the direction of leaf motion. The dynamic field delivered 540 MU either in 
a smooth sweep or with static pauses every 2 cm, in which additional dose was delivered.(2) 
The use of pauses created a situation in which a dynamic sweep and a series of matched static 
fields were superposed. In Pinnacle3, the fields were modeled as a summation of apertures at 
intervals of 0.1 cm across the 20 cm leaf sweep.
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c.   VMAT planning
VMAT treatment plans for five typical head-and-neck patients were created using the beam 
model. The clinical diagnoses for the five patients were: squamous cell carcinoma (SCC) of the 
base of the tongue, SCC hypopharnyx, SCC tonsil, follicular carcinoma of the thyroid gland, 
and metastatic ductal carcinoma of the breast. The clinical target volumes (CTVs) consisted 
of the region of primary disease (CTV1) and the bilateral neck nodes (CTV2). The planning 
target volumes were created by adding a uniform 0.3 cm margin to these CTVs, and the nodal 
PTV (PTV2) was excluded from the primary PTV (PTV1) so as to obviate conflicts in the 
optimization. Both PTVs were edited back from the skin surface by approximately 0.5 cm so 
as to prevent the treatment planning system from attempting to boost the dose in the build-up 
region. The spinal cord and brainstem were contoured and planning risk volumes (PRVs) cre-
ated by adding 0.3 cm margins. The whole parotid glands and the superficial parotid glands 
were also contoured. The prescribed dose was 65 Gy in 30 fractions to PTV1 and 54 Gy in 30 
fractions to PTV2 simultaneously.(6)
The VMAT beam arrangement was a single anticlockwise arc from gantry 179° to gantry 
181°. In the optimization, the principal objectives were to minimize the dose variation in the 
PTVs and to minimize mean dose to the parotid glands (aiming for below 24 Gy), while main-
taining a maximum spinal cord PRV dose of 48 Gy to 1 cm3 and a maximum brainstem PRV 
dose of 55 Gy to 1 cm3. The maximum delivery time was specified as 400 s, and an additional 
constraint of 0.8 cm/° on MLC motion was applied, as for clinical head-and-neck VMAT pro-
tocols at this center. Without this constraint, on control points where the gantry was moving at 
considerably less than maximum speed thereby taking a relatively long time to pass through 1° 
of arc, the leaves would have been allowed to move a considerable distance in that time. The 
constraint prevented this from happening. Pinnacle3 calculated the dose distribution according 
to the leaf positions at the discrete control points and by limiting the leaf motion, the actual 
leaf positions between the control points were constrained to be not far from those used for 
dose calculation, thereby improving accuracy. Note that with the gantry moving at full speed, 
the Agility MLC leaves can move 0.55 cm/° and the MLCi leaves can move 0.36 cm/°. If the 
gantry slows to around half maximum speed, the practical planning constraint of 0.8 cm/° 
starts to take effect.
The plans were compared with corresponding clinically treated plans for an accelerator with 
an MLCi head. In this case, the maximum leaf speed was set in the beam model to 2.0 cms-1. 
The minimum leaf gap was 2 cm and the maximum delivery time was again 400 s.
The Agility and MLCi treatment plans were then delivered on their respective accelerators. 
The maximum dose rates of both Agility and MLCi accelerators were between 540 and 550 
monitor units (MU) per minute. The plans on the MLCi unit were delivered using binned dose 
rate (i.e., 540 MU/min, 270 MU/min, 135 MU/min, etc.) as this was the only option available 
on this unit, but on the Agility unit the plans were delivered using both binned and continuously 
variable dose rate (CVDR) to investigate the effect of this factor on the resulting treatment time 
and delivery accuracy. The treatment plans were verified using a Delta4 phantom (ScandiDos, 
Uppsala, Sweden)(7) using a gamma evaluation for 3% of the dose to the primary PTV and 
0.3 cm distance to agreement. Following the normal procedure at this center, measurements 
less than 20% of the dose to the primary PTV were excluded from the analysis so as to avoid 
considering irrelevant regions receiving low dose. However, for the large treatment volumes 
in this study, the 20% isodose encompassed almost the entire diode array, so that the number 
of diodes excluded were few. The results were considered in relation to a clinical pass criterion 
that ideally 95% of measurements, and an absolute minimum of 90% of measurements, should 
have a gamma value of less than unity. Since the Delta4 phantom had been extensively com-
missioned and widely used at this center,(7) confidence in the results was such that no further 
verification measurements were considered necessary for VMAT verification.
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Statistical analysis was performed on the planning and delivery statistics using a Wilcoxon 
matched-pair signed-rank test in SPSS (IBM, Armonk, New York). Statistical significance was 
taken as p < 0.05.
 
III. rESuLTS 
A.   Beam modeling
The beam model has broadly similar parameters to those of an MLCi model, but with the MLC 
dimensions and transmission modified. The key parameters in the model are summarized in 
Table 2, and comparisons of the model with measured data are shown in Fig. 2.
The verification of irregular fields shows a good agreement between the measured and planned 
dose profiles for the L-shape and S-shape fields (Fig. 3). For the complete set of irregular fields, 
the mean agreement between measured and planned dose is 1.3% (planned dose higher), with 
a maximum difference of 3.2%. Figure 4 summarizes the absolute dose results for the main 
irregular fields.
The dynamic fields show an agreement between planned and measured dose of 0.5% (planned 
dose higher) without pauses and -1.1% (planned dose lower) with pauses.
Table 2. Summary of the Pinnacle3 model parameters, with the parameters of the MLCi model for comparison.  
 Parametera Agility Value MLCi Value
Source A-B dimension (cm) 0.01 0.01
Source G-T dimension (cm) 0.01 0.01
Gaussian height (cm) 0.04 0.05
Gaussian width (cm) 1.0 1.0
Off-axis softening factor 10.48 10.76
Xb-collimator transmission (%) 1.5c 9.5
Yb-collimator transmission (%) 1.5 0.1
MLC transmission (%) 0.5 0.1
Leaf tip radius (cm) 17.0 15.0
Tongue-and-groove width (cm) 0.1 0.175
Interleaf leakage transmission (%) 0.2 3.0
Maximum gantry speed (°s-1) 5.5 5.5
Maximum collimator speed (cms-1) 8.5 1.5
Maximum MLC leaf speed (cms-1) 3.0 2.0
aThe reader is referred to Starkschall et al.(5) for a description of the parameters.
bIEC61217 convention.
cNot applicable in practice, as the Agility head does not have X-collimators.
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Fig. 2. Comparisons of the Agility beam model (yellow dotted lines) with the corresponding measured data (solid red lines) 
for representative simple fields. These fields are among those used to produce the beam model. The central axis percentage 
depth dose and two orthogonal central axis profiles at 1.5 cm deep are shown in each case. The profiles in the direction of 
the multileaf collimator leaf motion are offset by 0.25 cm from the central axis so as to measure dose under a leaf rather 
than between leaves. Depth doses are normalized to 10 cm deep and profiles are normalized to the central axis. X and Y 
refer to IEC 61217, and positive X is directed towards X1 and positive Y is directed towards Y2. Distances are in cm.
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Fig. 3. Comparisons of the Agility beam model (yellow dotted lines) with the corresponding measured data (solid red 
lines) for the S-shape field. The central axis percentage depth dose and two orthogonal central axis profiles at 5 cm, 10 cm, 
and 20 cm deep are shown. The profiles in the direction of the multileaf collimator leaf motion are offset by 0.25 cm from 
the central axis so as to measure dose under a leaf rather than between leaves. Depth dose is normalized to 1.6 cm deep 
and profiles are normalized to the central axis. X and Y refer to IEC 61217, and positive X is directed towards X1 and 
positive Y is directed towards Y2. Distances are in cm.
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Fig. 4. Typical verification results for the irregularly shaped fields at 10 cm depth in Solid Water. Planned doses are given 
with respect to measured doses: (a) L-shape field, (b) S-shape field.
(a)
(b)
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B.  VMAT planning
The difference between Agility and MLCi collimation is illustrated in Fig. 5 for one of the 
VMAT head-and-neck plans, and a typical dose distribution created with the Agility model is 
shown in Fig. 6. Mean statistics are shown in Table 3 for the head-and-neck plans. The plans 
show comparable dose statistics to an MLCi unit, the monitor units being the only feature to 
show a statistically significant difference between the MLCi and the Agility.
(a)
(b)
Fig. 5. Beam’s eye view of the control point at gantry angle 179° using (a) Agility and (b) MLCi.
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A typical verification result in Delta4 for an Agility delivery with CVDR is shown in Fig. 7. 
Delivery times and verification results are summarized more fully in Table 4. Results are shown 
for both binned dose rate and CVDR, to facilitate a like-for-like comparison with the MLCi 
unit, for which binned dose rate has been used.
 
Fig. 6. Representative coronal dose distribution for one of the Agility plans, showing the primary PTV (pink) and nodal 
PTV (purple).
Table 3. Mean statistics for the head-and-neck plans.
 Constraint/Goal Mean Dose ± 1 SD (Gy)a
 Region Of Interest Volume Dose (Gy) Agility MLCi
PTV1edited 99% >58.5 61.7±0.4 61.6±0.6
 95% >61.8 62.8±0.2 62.8±0.3
 50% 65 65.2±0.0 65.2±0.0
  5% <68.3 67.1±0.2 67.1±0.3
  2% <71.5 67.5±0.2 67.5±0.4
PTV2edited 99% >48.6 51.2±0.4 51.4±0.3
 95% >51.3 52.0±0.3 52.2±0.3
 50% 54 54.2±0.2 54.1±0.2
Spinal cord Maximum <46 44.3±1.0 44.3±1.1
Spinal cord 1 cm3 <45 40.8±1.2 41.0±0.4
Spinal cord PRV 1 cm3 <48 44.8±0.7 44.5±0.9
Brainstem Maximum <54 43.2±11.2 41.6±14.9
Brainstem 1 cm3 <50 35.9±15.0 35.6±15.4
Brainstem PRV 1 cm3 <55 42.5±10.4 41.6±12.9
Ipsilateral parotid Mean <24 36.5±6.1 37.3±6.7
Contralateral parotid Mean <24 30.3±5.5 31.0±5.2
Superficial parotids Mean <24 24.8±3.5 25.6±4.1
Total monitor units     531.9±66.4 477.1±27.3
aItems in bold are statistically significant at the p < 0.05 level.
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IV. dIScuSSIon
The Pinnacle3 beam model for the Agility head is similar in quality to previously described 
beam models with static delivery.(5,8) The model represents the Agility MLC accurately, thereby 
providing VMAT treatment plans which reflect the narrow MLC leaves, low leaf transmission 
and fast leaf speed. The similarity of the beam model to that for an MLCi head is not surprising, 
as the accelerator itself is the same for the two heads and only the collimating device is different. 
Fig. 7. Delta4 results for an Agility delivery with CVDR. The upper panels show the two planes of diodes in the phantom. 
The grayscale distribution and isodoses show the planned dose, normalized to the primary PTV dose. The colored squares 
show the gamma value (3% and 3 mm) for the measured dose. The lower graphs are histograms of dose difference, distance 
to agreement, and gamma for the measured dose with respect to the planned dose. In this case, 97.3% of measurements 
have a gamma value of less than unity, the pass criterion of 90% being shown in brackets above the gamma histogram.
Table 4. Mean ± 1 SD statistics for beam delivery and verification using binned dose rate and continuously variable 
dose rate (CVDR).
 Agilitya MLCi
 Binned Dose Rate CVDR Binned Dose Rate
Delivery time (s) 171.4±10.4 132.6±7.4 281.8±100.0
Verification gamma (3%/3 mm) 95.0±2.9 95.2±2.8 96.2±1.3
aItems in bold are statistically significant at the p < 0.05 level, compared against the MLCi.
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Some of the Pinnacle3 parameters are not necessarily physical, but provide dosimetric results 
which match the delivered dose. For example, the MLC transmission of the Agility head is not 
actually higher than that of the MLCi head. Note also that the tongue-and-groove width used 
in the model is not physically real, as the accelerator has defocused leaves without a physical 
tongue and groove.(9,10) This approximated behavior in Pinnacle3 and other treatment planning 
systems is well known.(5) The physical speeds of the gantry, collimators, and MLC leaves are 
also chosen to be slightly conservative so as not to stress the delivery system, in accord with 
our clinical VMAT procedure. The delivery system adjusts the actual speeds according to its 
own accelerator-specific variables.
The results of the irregular field tests show that the beam model predicts dose mostly to 
within 2%, with a maximum discrepancy of 3%. These results vary by ± 1%, depending upon 
whether the Solid Water used for the practical measurements is modeled in Pinnacle3 as a 
water phantom of unit density, a density-overridden phantom of the exact density (1.03 gcm-3) 
of the Solid Water, or a volume represented by a CT scan, in conjunction with an appropriate 
CT-to-density table. However, the overall results in these cases are similar to those given in 
Fig. 4 for a water phantom. These results are very similar to those reported previously.(8,11,12) 
The maximum discrepancy of 3% is unlikely to manifest itself clinically, but the general trend 
for planned dose to be around 1% higher than measured dose in irregular fields manifests itself 
in the VMAT verification results, where measured dose is typically 1%–2% low on average 
(see Fig. 7). The accuracy of the calculated dose in the irregular fields depends mostly on the 
accuracy of the calculated head scatter and phantom scatter, so that adjustment of the beam 
model itself to improve the results is ineffective. A predominance of long, narrow apertures in 
VMAT beams also tends to cause the overestimation of output factor, which similarly contrib-
utes to slightly low measured dose during VMAT verification. This is also difficult to adjust. 
Methods for improving the calculated output factors are the subject of ongoing work. Despite 
these limitations, the dynamic fields demonstrate that the beam model is capable of accurately 
predicting the dose delivered by a dynamic sliding window.
Narrower leaf width and lower transmission have both been shown to improve dose distri-
butions for fixed-gantry intensity-modulated radiotherapy (IMRT).(13,14) Although neither of 
these studies is based specifically on the Agility head, the studies indicate that improvements 
in target coverage, mean parotid dose, and dose conformality are possible with narrower leaf 
width and lower interleaf transmission. In this study, the plans for the Agility and MLCi units 
are roughly equivalent. There is an indication in the results that the parotid mean dose may be 
lower with the Agility head than with the MLCi head, but this is not statistically significant. 
However, this is not to say that the head does not provide superior dose quality in other situa-
tions. For example, treatment of brain tumors with conformal static beams or conformal arcs 
may benefit from the narrow leaves, due to the ability to closely follow the shape of the PTV in 
the beam’s eye view. The situation may also be different with VMAT compared to static-gantry 
IMRT. It is likely that in VMAT delivery, the motion of the leaves spreads out the distribution 
of dose so that the effect of the narrow leaves is less noticeable. The results of this study are, of 
course, also specific to the Pinnacle3 treatment planning system, although comparable results 
are expected from other treatment planning systems.
The faster leaf speed of the Agility MLC is shown to be very beneficial for treatment delivery. 
The most prominent result in this study is that VMAT can be delivered extremely efficiently with 
the Agility head. Even with binned dose rate, which can be directly compared with delivery on 
the MLCi unit, there is a 40% reduction in delivery time and, with CVDR turned on, which is 
the normal delivery mode for the Agility accelerator, the delivery time is reduced by over 50%. 
The CVDR has been shown in other studies to improve the delivery speed of an MLCi unit by 
around 20%(15,16) and this effect is also present with the Agility head. The overall result is that 
a high-quality dose distribution is delivered in just over two minutes. The verification results 
show that the accuracy of delivery is not compromised by this speed. The gamma results meet 
the clinical criterion used at this center, which is normally met by VMAT head-and-neck plans 
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delivered on an MLCi unit. Note that the verification accuracy is considerably in excess of the 
85% of measurements within 5% and 5 mm required by ICRU 83.(17)
 
V. concLuSIonS
Pinnacle3 models the Agility MLC accurately, thereby providing VMAT treatment plans which 
reflect the narrow MLC leaves, low leaf transmission, and fast leaf speed. These treatment 
plans are dosimetrically equivalent to those for an MLCi unit, and delivery of VMAT on the 
Agility unit is significantly faster than on the MLCi. Following the measurement of beam data, 
commissioning of the beam model, and verification of the dose distributions, the Agility head 
is fit for clinical use.
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